Norbert Nass

13PUBLICATIONS
11CO-AUTHORS
Cancer diagnosisMolecular targetsInfectious diseasesMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 27, 2026
Inflammation and Colorectal Cancer Pathogenesis: Molecular, Immunological, and Environmental Features for Therapy Response and Resistances.

|Nov 25, 2023
Inhibition of EIF2α Dephosphorylation Decreases Cell Viability and Synergizes with Standard-of-Care Chemotherapeutics in Head and Neck Squamous Cell Carcinoma.

Anna M Cyran, Florian Kleinegger, Norbert Nass

|Feb 24, 2023
Monoclonal Antibody Therapy for COVID-19: A Retrospective Observational Study at a Regional Hospital.

Judith Pannier, Norbert Nass, Mohamad-Kamal Yaakoub

|Jul 27, 2022
Relationship of micro-RNA, mRNA and eIF Expression in Tamoxifen-Adapted MCF-7 Breast Cancer Cells: Impact of miR-1972 on Gene Expression, Proliferation and Migration.

Akhil Behringer, Darko Stoimenovski, Martin Porsch

|Jan 12, 2022
BCL3 expression is strongly associated with the occurrence of breast cancer relapse under tamoxifen treatment in a retrospective cohort study.

Piotr Czapiewski, Maximilian Cornelius, Roland Hartig

|Apr 03, 2021
Interactome Mapping of eIF3A in a Colon Cancer and an Immortalized Embryonic Cell Line Using Proximity-Dependent Biotin Identification.

Diep-Khanh Vo, Alexander Engler, Darko Stoimenovski

Pageof 3

Frequent Collaborators

2 joint publications

Ivo Grosse

2 joint publications

Diep-Khanh Vo

2 joint publications

Michael Naumann

1 joint publications

Martin Porsch